Molecular Classification
Transporter, Translocase, Membrane protein superfamily
Other Names
ABC transporter, ATP-binding cassette (ABC) transporter, ABC cassette transporter, ABC protein
Disease Roles
Cancer (multidrug resistance)Cystic fibrosisInherited metabolic disorders

ATP-binding cassette transporter protein Overview

ATP-binding cassette transporter proteins (ABC transporters) are a large superfamily of multipass transmembrane proteins that utilize the energy from ATP hydrolysis to transport a wide variety of substrates—including ions, amino acids, peptides, lipids, metabolites, drugs, and toxins—across biological membranes. They are found in all kingdoms of life and are characterized by conserved nucleotide-binding domains (NBDs) and transmembrane domains (TMDs). In humans, at least 48 distinct ABC transporter genes exist, grouped into subfamilies (ABCA–ABCG), many of which play crucial roles in drug efflux, absorption, and resistance, regulation of physiological substrate levels, and disease processes such as cancer multidrug resistance and cystic fibrosis. ABC transporters may be importers or exporters and are implicated in essential cellular functions as well as numerous inherited and acquired human diseases. Their activity can profoundly affect the pharmacokinetics of multiple drug classes and influence patient response and safety profiles.

Mechanism of Action

Substrate efflux to reduce intracellular drug/toxin concentration (drug resistance) ATP hydrolysis–driven conformational change to mediate substrate transport Maintenance of concentration gradients across membranes

Biological Functions

Transport of molecules across cell membranes
Drug efflux and resistance
Nutrient absorption
Toxin and metabolite export
Regulation of ion channels
Cell signaling (via substrate concentrations)
Cell division (select members in bacteria)

Disease Associations

Cancer (multidrug resistance)
Cystic fibrosis
Inherited metabolic disorders
Cholestasis
Neurodegenerative disease
Infection
Other

Safety Considerations

  • Development of multidrug resistance limits chemotherapy efficacy
  • Broad substrate specificity complicates drug-drug interactions
  • Polymorphisms associated with variable drug response and adverse effects
  • Potential for unintended impacts on absorption/excretion of endogenous substances

Interacting Drugs

Chemotherapeutic drugs (e.g., doxorubicin, paclitaxel)
Antibiotics (e.g., tetracyclines)
Antifungals
Immunosuppressives (e.g., cyclosporine)
Antiretrovirals (e.g., protease inhibitors)
Statins
Other (broad substrate specificity in many ABC family members)

Associated Biomarkers

Biomarker
ABCB1 (P-glycoprotein) expression for multidrug resistance in cancers
ABCC7 (CFTR) mutation for cystic fibrosis
Expression of specific ABC subtypes in tissue for drug response or disease characterization